Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 18 2024
0mins
Source: Globenewswire
Alpha Tau Medical Announcement: Alpha Tau Medical Ltd. has had an abstract accepted for presentation at the 2025 ASCO Gastrointestinal Cancers Symposium regarding their alpha-radiation cancer therapy, Alpha DaRT, specifically focusing on its application in pancreatic adenocarcinoma.
Upcoming R&D Update Day: The company will host an R&D Update Day on January 27, 2025, to discuss new data from clinical trials, including findings related to safety and efficacy of Alpha DaRT, as well as its potential use in combination therapies for various cancers.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
